CLINICAL_TRIALS
trial_result
· 2025-07-23
Clinical Trial Update: Study Evaluating the Safety and Efficacy of AR-15512 [Phase 3]
Summary
Phase 3 trial evaluating AR-15512 for dry eye disease has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aerie Pharmaceuticals | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-07-23